Hims & Hers Health (NYSE:HIMS) fell ~19% in the premarket on Tuesday, even as the telehealth company reported better-than-expected Q4 2024 financials and set its 2025 outlook above consensus during ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback